Reata Pharmaceuticals Inc

AMERIPRISE FINANCIAL INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

89,771

Value ($000)

9,153

Weight

0.0%

2019 Q4 - 2023 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	9,153	0.0%	89,771	6/30/2023
2023 Q1	5/22/2023	489	0.0%	5,375	3/31/2023
2022 Q4	2/14/2023	343	0.0%	9,016	12/31/2022
2022 Q3	11/14/2022	205	0.0%	8,190	9/30/2022
2021 Q3	11/15/2021	304	0.0%	3,015	9/30/2021
2021 Q2	8/16/2021	14,609	0.0%	103,226	6/30/2021
2021 Q1	5/17/2021	10,243	0.0%	102,734	3/31/2021
2020 Q4	2/12/2021	9,822	0.0%	79,453	12/31/2020
2020 Q3	11/16/2020	5,892	0.0%	60,475	9/30/2020
2020 Q2	8/14/2020	37,580	0.0%	240,868	6/30/2020
2020 Q1	5/15/2020	31,030	0.0%	214,971	3/31/2020
2019 Q4	2/14/2020	22,214	0.0%	108,666	12/31/2019